MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Modeling Parkinson’s disease pathology by combined injection of fibrilar and monomeric α-synuclein in rat brain

    P. Thakur, L. Breger, M. Lundblad, O. Wan, B. Mattsson, K. Luk, V. Lee, J. Trojanowski, A. Björklund (Frankfurt, Germany)

    Objective: Development of a fast and progressive Parkinson’s disease (PD) model in rat Background: α-Synuclein is a common link between sporadic and familial PD. Rodent…
  • 2017 International Congress

    Gait disturbance and olfactory dysfunction is associated with central cholinergic dysfunction in early Parkinson’s disease

    E. Oh, Y. Lim, S. Park (Daejeon, Republic of Korea)

    Objective: We hypothesis that olfactory dysfunction, could be an independent predictor of gait disturbance in early PD. Background: The pathophysiology of gait disturbance is not fully…
  • 2017 International Congress

    Brain insulin resistance in Parkinson’s disease

    F. Bassil, M.-H. Canron, N. Dutheil, A. Vital, E. Bezard, P.-O. Fernagut, W. Meissner (Bordeaux, France)

    Objective: To test the hypothesis that brain insulin resistance (i.e. decreased insulin/insulin like growth factor (IGF)-1 signaling) occurs in the substantia nigra pars compacta (SNc)…
  • 2017 International Congress

    Analysis of serum non-mercaptoalbumin in patients with Parkinson’s disease

    S. Ueno, T. Hatano, Y. Ouji, S. Saiki, H. Ikeda, N. Hattori (Tokyo, Japan)

    Objective: It is well known that the oxidative stress might be associated with the pathomechanisms of Parkinson’s disease (PD). In this study, we assessed serum…
  • 2017 International Congress

    The effects of dual task on the finger tapping performance of Parkinson’s disease.

    A. Miyake, T. Yamamoto, H. Kawasaki, T. Furuya, T. Fukuoka, K. Takahashi, N. Tamura, N. Araki (irumagun moroyama town, Japan)

    Objective: In the present study, we aim to analyze the effects of a dual task on repetitive finger tapping (FT) performance in patients with Parkinson’s…
  • 2017 International Congress

    Potential of non-invasive brain stimulation to ameliorate freezing of gait in Parkinson’s disease: A deep repetitive TMS randomized, double-blinded, cross-over pilot study

    M. Dagan, T. Herman, A. Mirelman, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

    Objective: To investigate the impact of deep transcranial magnetic stimulation (TMS) of the medial prefrontal cortex (mPFC) on freezing of gait (FOG) in Parkinson’s disease…
  • 2017 International Congress

    Neuroinflammation in the substantia nigra is triggered by synucleinopathy and precedes nigral degeneration

    M. Duffy, T. Collier, K. Luk, M. Tansey, K. Paumier, D. Fischer, N. Polinski, C. Kemp, C. Sortwell (Grand Rapids, MI, USA)

    Objective: To determine the relationship between synucleinopathy, neuroinflammation and nigrostriatal degeneration using the rat α-syn PFF model. Background: No therapy exists to halt or slow…
  • 2017 International Congress

    Characterizing the Bcl-2 Associated Athanogene 5 Interactome

    E. Friesen, X. Wang, D. Williams, H. Chau, M. De Snoo, O. Pellerito, L. Kalia, G. Schmitt-Ulms, S. Kalia (Toronto, ON, Canada)

    Objective: Characterizing the Bcl-2 Associated Athanogene 5 (BAG5) interactome will uncover the molecular pathways with which BAG5 associates and further elucidate its role in dopaminergic…
  • 2017 International Congress

    Neuroprotective Potency of Tetrahydroisoquinoline a Novel Ayurveda Molecule in Experimental Parkinson’s Disease

    R. Banerjee, D. Nthenge-Ngumbau, R. Singh, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Tetrahydroisoquinoline (TIQ) an identified alkaloid from ancient Indian ‘Ayurveda’ medicine for Parkinson’s disease (PD) was tested for neuroprotection in a cellular system and a…
  • 2017 International Congress

    Alpha-synuclein enhances histone H3 lysine-9 dimethylation

    N. Sugeno, S. Jäckel, A. Voigt, T. Hasegawa, P. Kahle (Tübingen, Germany)

    Objective: To explore the nuclear function of alpha-synuclein (αS). Background: αS is a protein linked to Parkinson’s disease (PD) and related neurodegenerative disorders. It is…
  • « Previous Page
  • 1
  • …
  • 1244
  • 1245
  • 1246
  • 1247
  • 1248
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley